Skip to main content

Nigeria Archives

NIH grant bolsters childhood status epilepticus and epilepsy research in Nigeria

Mar. 2, 2021—The Vanderbilt Institute for Global Health (VIGH) has received a new research grant from the National Institute of Neurological Disorders and Stroke and Fogarty International Center of the NIH to establish a large childhood status epilepticus (SE) cohort in northern Nigeria with key partners Aminu Kano Teaching Hospital (AKTH) and Bayero University, and with the Sydney Brenner Institute for Molecular Bioscience at the University of the Witwatersrand (Wits) in South Africa.

Read more


HIV patients stay away after Nigerian clinic introduces fees

Dec. 10, 2020—Six years ago, in Nigeria, funding cutbacks for HIV treatment and the consequent introduction of patient fees were associated with sharp declines in new HIV clinic enrollments and patient adherence to antiretroviral therapy (ART).

Read more


VIGH awarded $3 million for building research capacity in Nigeria and Mozambique

Jun. 9, 2020—Vanderbilt Institute for Global Health (VIGH) has received a new research training grant and a renewal for an existing training program from the Fogarty International Center (FIC) of the National Institutes of Health (NIH) to build HIV-focused research capacity with key partners in Nigeria and Mozambique.

Read more


VIGH study seeks to expand epilepsy care efforts in Africa

Oct. 10, 2019—The Vanderbilt Institute for Global Health (VIGH), with Aminu Kano Teaching Hospital (AKTH), will conduct a clinical trial in three cities in northern Nigeria to determine the efficacy of shifting childhood epilepsy care to epilepsy-trained community health extension workers.

Read more


VIGH receives federal grants to fight kidney disease

Oct. 12, 2017—Researchers in the Vanderbilt Institute for Global Health (VIGH) have received two new grants from the National Institutes of Health (NIH) aimed at reducing the risk of kidney disease in HIV-infected adults and improving the treatment of epilepsy in children in Nigeria.

Read more


Two Ebola Survivors’ Blood Could Help Vanderbilt Researchers Find A Treatment

Oct. 19, 2015—Vanderbilt researchers could be one step closer to finding a way to fight the deadly Ebola virus – thanks to two Ebola victims from Nigeria, who faced death and survived. Vanderbilt researchers developed a unique method of isolating potent Ebola-fighting antibodies from survivors’ blood and they believe these newest potent antibody samples are an important...

Read more


Study seeks to ease HIV transmission rates in Nigeria

Nov. 8, 2012—Researchers at the Vanderbilt Institute for Global Health (VIGH) have received a major federal grant to study whether an integrated, family-focused approach can prevent mother-to-child transmission of HIV — the AIDS virus — in Nigeria.

Read more


Project targets sickle cell disease in Nigeria

Oct. 25, 2012—Researchers from the Monroe Carell Jr. Children’s Hospital at Vanderbilt and Aminu Kano Teaching Hospital in Kano, Nigeria, will work on a collaborative project to study a sickle cell disease treatment for children in Nigeria.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more